What horror movies have earned the most at the box office?
Horror movies keep rewriting the box-office playbook, and the current leaderboard shows both long-standing classics and fresh surprises sitting at the top. The list changes slightly depending on whether sources count re-releases or borderline genre entries, yet the leaders remain consistent in one respect: they balance brand recognition with genuine audience appetite. Recent 2025 and 2026 releases prove that studios can still deliver outsized returns if the story, timing, and budget align.
Record holder stays put
It (2017) continues to sit at the top of every unadjusted worldwide ranking. The Stephen King adaptation cleared roughly 704 million dollars on a 35 million dollar budget, a result that still stands as the highest-grossing horror movie to date. Its September opening of 123 million domestic dollars set a record for R-rated horror and proved the genre could deliver summer-style numbers in the fall.
The film’s success rested on strong word-of-mouth and broad demographic appeal. Families and young adults turned out in equal numbers, a pattern studios have tried to replicate ever since. Re-releases have added a few million dollars, yet the original run remains the benchmark.
Guinness World Records still lists the title as the global leader, a distinction that shapes how producers approach upcoming Stephen King projects and other high-profile adaptations.
Franchise endurance pays off
The Conjuring: Last Rites (2025) finished just shy of 500 million dollars worldwide, the strongest single entry in the long-running series. The picture opened to roughly 83 million domestic dollars, another franchise record, and benefited from a built-in audience that already trusted the Ed and Lorraine Warren brand.
International markets contributed more than half the total gross, an outcome that mirrors the series’ history of outsized overseas earnings. The result also pushed the broader Conjuring Universe past 2.9 billion dollars, making it the highest-grossing horror franchise by a clear margin.
Studio executives now cite the film’s September release window as a strategic template, proving that a proven IP can still open big outside the usual summer corridor.
Low-budget breakout rewrites math
Obsession (2026) arrived with little fanfare and a reported budget of 750 thousand dollars, then collected about 520 million dollars worldwide. The romantic-comedy subversion angle helped the film play wider than typical horror titles, while strong word-of-mouth kept it in theaters for months.
Focus Features, the distributor, recorded its largest opening weekend ever on the picture. The result also challenged assumptions that only established franchises can reach the upper ranks of horror earnings.
Producers are already fast-tracking similar micro-budget projects, betting that lean overhead plus high-concept storytelling can deliver returns once reserved for nine-figure productions.
Classic benchmarks still count
Jaws (1975) remains the earliest film to crack 100 million domestic dollars, finishing its original run near 495 million worldwide. The picture’s summer saturation campaign created the modern blockbuster calendar and set expectations for horror openings that later titles still chase.
The Exorcist (1973) sits just below it at roughly 441 million unadjusted, boosted by periodic re-releases that keep adding to the total. Both films continue to surface in conversations about inflation-adjusted lists, yet they also demonstrate how long-tail earnings can accumulate over decades.
These older titles serve as reference points whenever studios weigh the value of catalog marketing versus new productions.
Sequels maintain momentum
It: Chapter Two (2019) cleared about 473 million dollars, a figure that ranks among the strongest horror sequels ever. The follow-up opened slightly below the original but held better than most second chapters, thanks to the built-in audience that returned for closure.
Beetlejuice Beetlejuice (2024) collected 452 million dollars, proving that long-dormant properties can still deliver when nostalgia aligns with current cultural chatter. The film’s marketing leaned on generational recognition while adding enough fresh material to satisfy younger viewers.
Both pictures illustrate the current industry preference for known quantities that can open wide without heavy educational spend.
Original titles find space
Sinners and Weapons, both 2025 originals, posted domestic totals that placed them inside the year’s top ten horror earners. Their success rested on contained premises, modest budgets, and marketing campaigns that treated social-media conversation as a primary driver rather than an afterthought.
Backrooms (2026) followed a similar path for A24, becoming the distributor’s highest-grossing release with more than 400 million dollars worldwide. The film’s meme-friendly concept helped it reach audiences outside traditional horror circles.
These results suggest studios are carving out release dates for lower-cost originals rather than filling every slot with sequels.
Borderline entries spark debate
Some lists include films such as Alien: Romulus (2024) or Doctor Strange in the Multiverse of Madness because they contain horror DNA, yet pure-horror rankings often exclude them. The distinction matters for awards positioning and for how studios allocate genre-specific marketing budgets.
Industry trackers note that international audiences are less concerned with strict labels, which explains why certain sci-fi or superhero titles post stronger overseas numbers than domestic ones.
The ongoing discussion influences which projects receive horror-centric trailers and which ones are positioned as straight genre plays.
Profitability shapes greenlights
Obsession’s reported return on investment exceeds 600-to-1, a ratio that dwarfs most tent-pole productions. Studios now run internal models that weigh such outliers against the safer but lower-margin returns of established franchises.
The Conjuring series, despite higher budgets, still clears substantial profit after international and ancillary revenue streams are counted. This dual-track approach—low-risk sequels paired with occasional high-upside originals—has become the dominant strategy.
Agents and producers report that financiers are asking for horror pitches that can be shot for under ten million dollars, betting that the genre’s built-in audience will reward disciplined spending.
Release windows keep shifting
September and October slots once considered dumping grounds now host some of the year’s biggest horror openings. It, The Conjuring: Last Rites, and several 2025 originals all chose fall dates to avoid summer competition while capitalizing on seasonal mood.
Exhibitors have responded by extending playtime for titles that hold well, a change from earlier decades when horror films often disappeared after three weeks. The longer runs increase total grosses and reduce the need for expensive re-marketing campaigns.
Analysts expect the pattern to continue as long as horror maintains its current share of the annual box-office pie.
Next cycle already forming
Studios are developing at least two new Stephen King adaptations and multiple Conjuring spin-offs, while simultaneously scouting micro-budget originals that can replicate Obsession’s multiplier. The pipeline suggests horror will remain a reliable profit center even if overall theatrical attendance stays flat.
Audience appetite shows no sign of narrowing; the same viewers who turned out for It are now sampling low-budget experiments and catalog re-releases with equal enthusiasm. The next record holder could emerge from either lane, provided the story lands and the numbers add up.
